share_log

HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $20

Benzinga ·  Oct 5, 2023 07:12

HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises the price target from $19 to $20.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment